Skip to main content

Table 1 Body and prostate weight in NBP, NBP-tadalafil, control and control-tadalafil groups

From: A phosphodiesterase 5 inhibitor, tadalafil, suppresses stromal predominance and inflammation in a rat model of nonbacterial prostatitis

  

Mean ± SD (g)

Group

No. Rats

Body weight

Prostate weight

NBP

10

561.9 ± 32.4**

0.45 ± 0.11**

NBP-tadalafil

10

581.4 ± 30.9**

0.65 ± 0.14**

Control

9

730.1 ± 52.4

1.34 ± 0.36

Control-tadalafil

10

694.8 ± 27.3

1.18 ± 0.43

  1. NBP nonbacterial prostatitis, NBP-tadalafil NBP with tadalafil treatment, Control-tadalafil Control with tadalafil treatment. Significant differences compared with control group, ** P < 0.01
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us